Differential effect of genistein on the stimulation of cholesterol production by basic protein II in normal and hyperapoB fibroblasts

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 1, 1998, Pages 57-64

  Kwiterovich Jr , Peter O ^a,b   Motevalli, Mahnaz ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Atherosclerosis; Familial combined hyperlipidemia; Tyrosine kinase phosphorylation

Indexed keywords

ACETIC ACID; APOLIPOPROTEIN B; BASIC PROTEIN; CHOLESTEROL; GENISTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MEVALONIC ACID; PROTEIN TYROSINE KINASE;

ARTICLE; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FIBROBLAST; HUMAN; HUMAN CELL; HYPERLIPOPROTEINEMIA; PHOSPHORYLATION; PRIORITY JOURNAL;

EID: 17344370224     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.1.57     Document Type: Article

References (29)

1. Kwiterovich PO Jr, Coresh J, Bachorik PS. Prevalence of hyperapoB and other lipoprotein phenotypes in premature coronary atherosclerosis. Am J Cardiol. 1993;71:631-639.
2. Coresh J, Kwiterovich PO Jr, Smith HH, Bachorik PS. Association of plasma triglyceride concentration and LDL particle diameter, density and chemical composition with premature coronary artery disease in men and women. J Lipid Res. 1993;34:687-697.
3. Kwiterovich PO Jr. Genetics and molecular biology of familial combined hyperlipidemia. Curr Opin Lipidol. 1993;4:133-143.
4. Teng B, Sniderman AD, Soutar AK, Thompson GR. Metabolic basis of hyperapobetalipoproteinemia: turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia. J Clin Invest. 1986;77:663-672.
5. Genest J, Snidennan AD, Cianflone K, Teng B, Wacloher S, Marcel Y, Kwiterovich P. Plasma lipoprotein responses to oral fat load. Arteriosclerosis. 1986;6:297-304.
6. Sniderman A, Kwiterovich PO Jr. Hyperapobetalipoproteinemia, and LDL, and HDL2 heterogeneity. Proceedings of the Workshop on Lipoprotein Heterogeneity. Washington, DC: US Department of Health and Human Services; 1987:293-304. Publication NIH 87-2646.
7. Teng B, Forse A, Rodriquez MA, Sniderman AD. Adipose tissue glyceride synthesis in patients with hyperapobetalipoproteinemia. Can J Physiol Pharmacol. 1988;66:239-242.
8. Kwiterovich PO Jr, Motevalli M, Miller M. Acylation-stimulatory activity in hyperapoB fibroblasts: enhanced cholesterol esterification with a new serum basic protein. Proc Natl Acad Sci U S A. 1990;87:8980-8984.
9. Kwiterovich PO Jr, Motevalli M, Miller M, Bachorik PS, Kafonek SD, Chatterjee S, Beaty TH, Virgil D. Further insights into the pathophysiology of hyperapobetalipoproteinemia. Clin Chem. 1991;37:317-326.
10. Kwiterovich PO Jr, Motevalli M, Miller M. The effect of three serum basic proteins on the mass of lipids in normal and hyperapoB fibroblasts. Arterioseler Thromb. 1994;14:1-7.
11. Kwiterovich PO, Motevalli M. Inhibition of protein tyrosine kinase alters the effects of serum basic protein I on triacylglycerols and cholesterol differently in normal and hyperapoB fibroblasts. Arterioscler Thromb Vasc Biol. 1995;15:1195-1203.
12. Bachorik PS, Virgil D, Motevalli M, Kwiterovich PO Jr. Altered high-affinity binding of basic proteins I (BP I) and II (BP II) to fibroblasts from hyperapoB patients. Circulation. 1996;94(suppl I):I-347. Abstract.
13. Cianflone KM, Snidennan AD, Walsh MJ, Vu HT, Gagnon J, Rodriguez MA. Purification and characterization of acylation-samulating protein. J Biol Chem. 1989;264:426-430.
14. Cianflone K, Vu H, Walsh M, Baldo A, Sniderman AD. Evidence for a critical role of cholesteryl ester synthesis in the response to a fatty acid challenge. J Lipid Res. 1989;30:1727-1733.
15. Baldo A, Snidennan AD, St-Luce S, Avramoglu RK, Maslowska M, Hoang B, Monge JC, Bell A, Mulay S, Cianflone K. The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis. J Clin Invest. 1993;92:1543-1547.
16. Yasruel Z, Cianflone K, Sniderman AD, Rosenbloom M, Walsh M, Rodriguez MA. Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue. Lipids. 1991;26:495-499.
17. Germinario R, Sniderman AD, Manuel S, Lefebvre SP, Baldo A, Cianflone K. Coordinate regulation of triacylglycerol synthesis and glucose transport by acylation-stimulating protein. Metabolism. 1993;40:574-589.
18. Cianflone K, Roncari DAK, Maslowska M, Baldo A, Forden J, Sniderman AD. Adipsin/acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis. Biochemistry. 1994;33:9489-9495.
19. Levitzki A, Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science. 1995;267:1782-1788.
20. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 1987;262:5592-5595.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
22. Goldstein JL, Brown MS. Familial hypercholesterolemia: identification of a defect in the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity associated with overproduction of cholesterol. Proc Natl Acad Sci U S A. 1973;70:2804-2808.
23. Kelly RI. Octenylsuccinic aciduria in children fed protein-hydrolysate formulas containing modified cornstarch. Pediatr Res. 1991;30:564-569.
24. Abler A, Smith JA, Randazzo PA, Rothenberg PL, Jarett L. Genistein differentially inhibits post-receptor effects of insulin in rats. J Biol Chem. 1992;267:3946-3951.
25. Motevalli M, Goldschmidt P, Virgil D, Kwiterovich PO Jr. Abnormal protein tyrosine phosphorylation in fibroblasts from hyperapoB subjects. J Biol Chem. 1997;272:24703-24709.
26. Bolen JB. Non-receptor tyrosine protein kinases. Oncogene. 1993;8:2025-2031.
27. 3 domains: elements that control interactions of cytoplasmic signaling protein. Science. 1992;252:668-674.
28. Sato R, Goldstein JL, Brown MS. Replacement of serine-871 of hamster 3-hydroxy-3-methylglutaryl CoA reductase prevents phosphorylation by an AMP-activated kinase and blocks inhibition of sterol synthesis induced by ATP depletion. Proc Natl Acad Sci U S A. 1993;90:9261-9265.
29. Kwiterovich PO Jr, Fredrickson DS, Levy RI. Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia): a study of its biochemical, genetic and clinical presentation in childhood. J Clin Invest. 1974;53:1237-1249.